Revance Therapeutics (RVNC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RVNC | ITOS | TCRX | ||
| Company | Revance Therapeutics | Iteos Therapeutics Inc | Tscan Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.92 | 11.72 | 8.79 | ||
| High | 4.07 | 11.92 | 9.09 | ||
| Low | 3.88 | 11.51 | 8.55 | ||
| Last | 3.95 | 11.66 | 8.56 | ||
| Change | +0.18 | +0.17 | -0.09 | ||
| % Change | +4.77% | +1.48% | -1.04% | ||
| Volume | 1,370,600 | 295,100 | 88,600 | ||
| 20-Day Average Volume | 1,861,310 | 239,355 | 236,700 | ||
| Previous Close | 3.77 | 11.49 | 8.65 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 3.88 | 11.29 | 7.52 | ||
| 20-Day Raw Stochastic | 42.77% | 49.40% | 78.88% | ||
| 20-Day Relative Strength | 43.05% | 52.51% | 63.98% | ||
| Weighted Alpha | -84.01 | -14.65 | +181.21 | ||
| Today's Opinion | 88% Sell | 56% Buy | 100% Buy | ||
| Previous Opinion | 100% Sell | 56% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Sell | 72% Buy | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +16.18% since 04/26/24 | +7.96% since 04/26/24 | +16.94% since 04/26/24 | ||
| Low | 3.41 on 04/29/24 | 10.60 on 05/01/24 | 7.38 on 04/30/24 | ||
| High | 4.07 on 05/03/24 | 11.92 on 05/03/24 | 9.09 on 05/03/24 | ||
| 1-Month | |||||
| %Chg | -13.19% since 04/03/24 | -11.13% since 04/03/24 | +19.55% since 04/03/24 | ||
| Low | 3.21 on 04/26/24 | 10.01 on 04/19/24 | 6.58 on 04/17/24 | ||
| High | 4.94 on 04/09/24 | 13.35 on 04/09/24 | 9.09 on 05/03/24 | ||
| 3-Month | |||||
| %Chg | -26.44% since 02/02/24 | +17.07% since 02/02/24 | +63.36% since 02/02/24 | ||
| Low | 3.21 on 04/26/24 | 9.70 on 02/16/24 | 5.11 on 02/05/24 | ||
| High | 7.56 on 03/01/24 | 13.80 on 04/01/24 | 9.09 on 05/03/24 | ||
| 6-Month | |||||
| %Chg | -57.20% since 11/03/23 | +12.77% since 11/03/23 | +109.80% since 11/03/23 | ||
| Low | 3.21 on 04/26/24 | 8.95 on 12/01/23 | 3.73 on 11/22/23 | ||
| High | 9.74 on 01/02/24 | 13.80 on 04/01/24 | 9.09 on 05/03/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 411,653 | 419,363 | 409,870 | ||
| Shares Outstanding, K | 104,216 | 35,966 | 47,882 | ||
| Annual Sales | 234,040,000 | 12,600,000 | 21,050,000 | ||
| Annual Net Income | -323,990,000 | -112,640,000 | -89,220,000 | ||
| Last Quarter Sales | 69,800,000 | 0 | 7,210,000 | ||
| Last Quarter Net Income | -55,700,000 | -30,550,000 | -19,610,000 | ||
| 60-Month Beta | 1.16 | 1.27 | 0.91 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.62 on 02/28/24 | -0.85 on 03/06/24 | -0.21 on 03/06/24 | ||
| Latest Earnings Date | 05/14/24 | 05/08/24 | 05/08/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||